Skip to main content

Table 3 Characteristics of radiation therapy for AVPM by treatment group

From: Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM

Characteristic Treatment group p-value
  cFSRT (n = 35) hSRT (n = 13)  
  28 × 180 cGy
(80% IDL)
EQD2 = 48–51.8 Gy Eq (α/β = 3)
5 × 450–600 cGy
(80% IDL)
EQD2 = 33.75–54 Gy Eq (α/β = 3)
 
Treatment year 2010 2014 p < 0.001
Median (range) (2004–2015) (2013–2015)  
Time from pretreatment neuro-ophthalmologic evaluation to first day of radiation treatment (Median in months) 3 2 p = 0.487
  1. AVPM anterior visual pathway meningioma; cFSRT conventionally fractionated stereotactic radiotherapy; cGy centigray; hSRT hypofractionated stereotactic radiotherapy; IDL Isodose Line; EQD2 Two Gy bioequivalent radiation dose